U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Naughton F, Hope A, Siegele-Brown C, et al. A smoking cessation smartphone app that delivers real-time ‘context aware’ behavioural support: the Quit Sense feasibility RCT. Southampton (UK): National Institute for Health and Care Research; 2024 Apr. (Public Health Research, No. 12.04.)

Cover of A smoking cessation smartphone app that delivers real-time ‘context aware’ behavioural support: the Quit Sense feasibility RCT

A smoking cessation smartphone app that delivers real-time ‘context aware’ behavioural support: the Quit Sense feasibility RCT.

Show details

References

1.
World Health Organization. Report on Global Tobacco Epidemic. Geneva: WHO; 2011.
2.
GBD 2019. Tobacco collaborators. spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet 2021;397:2337–60. 10.1016/S0140-6736(21)01169-7 [PMC free article: PMC8223261] [PubMed: 34051883] [CrossRef]
3.
Murray CJ, Richards MA, Newton JN, Fenton KA, Anderson HR, Atkinson C, et al. UK health performance: findings of the global burden of disease study 2010. Lancet 2013;381:997–1020. 10.1016/S0140-6736(13)60355-4 [PubMed: 23668584] [CrossRef]
4.
NHS Digital. Statistics on Smoking – England 2018: Statistics on Smoking. Part 1: Smoking-Related Ill Health and Mortality. 2018. URL: https://digital​.nhs.uk​/data-and-information​/publications/statistical​/statistics-on-smoking​/statistics-on-smoking-england-2018​/part-1-smoking-related-ill-health-and-mortality (accessed 27 April 2020).
5.
West R, Brown J. Smoking Toolkit Study (STS). 2017. URL: www​.smokinginengland.info/ (accessed 1 July 2017).
6.
Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB. Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 1994;271:589–94. 10.1001/jama.1994.03510320029025 [PubMed: 8301790] [CrossRef]
7.
Deiches JF, Baker TB, Lanza S, Piper ME. Early lapses in a cessation attempt: lapse contexts, cessation success, and predictors of early lapse. Nicotine Tob Res 2013;15:1883–91. 10.1093/ntr/ntt074 [PMC free article: PMC3790630] [PubMed: 23780705] [CrossRef]
8.
Shadel WG, Martino SC, Setodji C, Cervone D, Witkiewitz K, Beckjord EB, et al. Lapse-induced surges in craving influence relapse in adult smokers: an experimental investigation. Health Psychol 2011;30:588–96. 10.1037/a0023445 [PMC free article: PMC3158283] [PubMed: 21574708] [CrossRef]
9.
Shiffman S, Paty JA, Gnys M, Kassel JA, Hickcox M. First lapses to smoking: within-subjects analysis of real-time reports. J Consult Clin Psychol 1996;64:366–79. 10.1037/0022-006X.64.2.366 [PubMed: 8871421] [CrossRef]
10.
Naughton F, Hopewell S, Lathia N, Schalbroeck R, Brown C, Mascolo C, et al. A context-sensing mobile phone app (Q Sense) for smoking cessation: a mixed-methods study. JMIR Mhealth Uhealth 2016;4:e106. 10.2196/mhealth.5787 [PMC free article: PMC5045522] [PubMed: 27637405] [CrossRef]
11.
Conklin CA, McClernon FJ, Vella EJ, Joyce CJ, Salkeld RP, Parzynski CS, Bennett L. Combined smoking cues enhance reactivity and predict immediate subsequent smoking. Nicotine Tob Res 2019;21:241–8. https://doi.org/doi:10.1093/ntr/nty009 [PMC free article: PMC6329405] [PubMed: 29370401]
12.
Conklin CA, Perkins KA, Robin N, McClernon FJ, Salkeld RP. Bringing the real world into the laboratory: personal smoking and nonsmoking environments. Drug Alcohol Depend 2010;111:58–63. https://doi.org/doi:10.1016/j.drugalcdep.2010.03.017 [PMC free article: PMC2930143] [PubMed: 20510552]
13.
Ahnallen CG, Tidey JW. Personalized smoking environment cue reactivity in smokers with schizophrenia and controls: a pilot study. Psychiatry Res 2011;188:286–8. 10.1016/j.psychres.2011.04.005 [PMC free article: PMC3114290] [PubMed: 21550670] [CrossRef]
14.
Ferguson SG, Shiffman S. Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes. Psychopharmacology (Berl) 2014;231:2595–602. 10.1007/s00213-013-3429-6 [PubMed: 24408214] [CrossRef]
15.
Ferguson SG, Shiffman S. Effect of high-dose nicotine patch on the characteristics of lapse episodes. Health Psychol 2010;29:358–66. 10.1037/a0019367 [PubMed: 20658822] [CrossRef]
16.
Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat 2009;36:235–43. 10.1016/j.jsat.2008.06.005 [PubMed: 18715743] [CrossRef]
17.
Versace F, Stevens EM, Robinson JD, Cui Y, Deweese MM, Engelmann JM, et al. Brain responses to cigarette-related and emotional images in smokers during smoking cessation: no effect of varenicline or bupropion on the late positive potential. Nicotine Tob Res 2019;21:234–40. 10.1093/ntr/ntx264 [PMC free article: PMC6329398] [PubMed: 29220524] [CrossRef]
18.
Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res 2011;13:94–102. 10.1093/ntr/ntq215 [PMC free article: PMC3028191] [PubMed: 21147894] [CrossRef]
19.
Buss V, West R, Kock L, Kale D, Brown J. Smoking in England. 2022. URL: https:​//smokinginengland.info/ (accessed 23 November 2023).
20.
Brodbeck J, Bachmann MS, Znoj H. Distinct coping strategies differentially predict urge levels and lapses in a smoking cessation attempt. Addict Behav 2013;38:2224–9. 10.1016/j.addbeh.2013.02.001 [PubMed: 23501139] [CrossRef]
21.
O’Connell KA, Hosein VL, Schwartz JE. Thinking and/or doing as strategies for resisting smoking. Res Nurs Health 2006;29:533–42. 10.1002/nur.20151 [PubMed: 17131277] [CrossRef]
22.
Naughton F, McEwen A, Sutton S. Use and effectiveness of lapse prevention strategies among pregnant smokers. J Health Psychol 2015;20:1427–33. 10.1177/1359105313512878 [PubMed: 24296735] [CrossRef]
23.
Abroms LC, Lee WJ, Bontemps-Jones J, Ramani R, Mellerson J. A content analysis of popular smartphone apps for smoking cessation. Am J Prev Med 2013;45:732–6. 10.1016/j.amepre.2013.07.008 [PMC free article: PMC3836190] [PubMed: 24237915] [CrossRef]
24.
Thornton L, Quinn C, Birrell L, Guillaumier A, Shaw B, Forbes E, et al. Free smoking cessation mobile apps available in Australia: a quality review and content analysis. Aust N Z J Public Health 2017;41:625–30. 10.1111/1753-6405.12688 [PubMed: 28749591] [CrossRef]
25.
Vilardaga R, Casellas-Pujol E, McClernon JF, Garrison KA. Mobile applications for the treatment of tobacco use and dependence. Curr Addict Rep 2019;6:86–97. 10.1007/s40429-019-00248-0 [PMC free article: PMC6994183] [PubMed: 32010548] [CrossRef]
26.
Chu KH, Matheny SJ, Escobar-Viera CG, Wessel C, Notier AE, Davis EM. Smartphone health apps for tobacco cessation: a systematic review. Addict Behav 2021;112:106616. 10.1016/j.addbeh.2020.106616 [PMC free article: PMC7572657] [PubMed: 32932102] [CrossRef]
27.
Bricker JB, Watson NL, Mull KE, Sullivan BM, Heffner Jaimee L. Efficacy of smartphone applications for smoking cessation: a randomized clinical trial. JAMA Intern Med 2020;180:1472. 10.1001/jamainternmed.2020.4055 [PMC free article: PMC7506605] [PubMed: 32955554] [CrossRef]
28.
Garrison KA, Pal P, O’Malley SS, Pittman BP, Gueorguieva R, Rojiani R, et al. Craving to quit: a randomized controlled trial of smartphone app-based mindfulness training for smoking cessation. Nicotine Tob Res 2020;22:324–31. 10.1093/ntr/nty126 [PMC free article: PMC7297096] [PubMed: 29917096] [CrossRef]
29.
Perski O, Crane D, Beard E, Brown J. Does the addition of a supportive chatbot promote user engagement with a smoking cessation app? An experimental study. Digit Health 2019;5:80676. 10.1177/2055207619880676 [PMC free article: PMC6775545] [PubMed: 31620306] [CrossRef]
30.
Etter JF, Khazaal Y. The Stop-tabac smartphone application for smoking cessation: a randomized controlled trial. Addiction 2021;117:1406–15. 10.1111/add.15738 [PMC free article: PMC9298872] [PubMed: 34738687] [CrossRef]
31.
Perski O, Hebert ET, Naughton F, Hekler EB, Brown J, Businelle MS. Technology-mediated just-in-time adaptive interventions (JITAIs) to reduce harmful substance use: a systematic review. Addiction 2021;117:1220–41. 10.1111/add.15687 [PMC free article: PMC8918048] [PubMed: 34514668] [CrossRef]
32.
Free C, Knight R, Robertson S, Whittaker R, Edwards P, Zhou W, et al. Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial. Lancet 2011;378:49–55. 10.1016/S0140-6736(11)60701-0 [PMC free article: PMC3143315] [PubMed: 21722952] [CrossRef]
33.
Devries KM, Kenward MG, Free CJ. Preventing smoking relapse using text messages: analysis of data from the txt2stop trial. Nicotine Tob Res 2012;15:77–82. 10.1093/ntr/nts086 [PubMed: 22523120] [CrossRef]
34.
Naughton F, Cooper S, Foster K, Emery J, Leonardi-Bee J, Sutton S, et al. Large multi-centre pilot randomized controlled trial testing a low-cost, tailored, self-help smoking cessation text message intervention for pregnant smokers (MiQuit). Addiction 2017;112:1238–49. 10.1111/add.13802 [PMC free article: PMC5488183] [PubMed: 28239919] [CrossRef]
35.
Naughton F, Jamison J, Boase S, Sloan M, Gilbert H, Prevost AT, et al. Randomized controlled trial to assess the short-term effectiveness of tailored web- and text-based facilitation of smoking cessation in primary care (iQuit in Practice). Addiction 2014;109:1184–93. 10.1111/add.12556 [PMC free article: PMC4309513] [PubMed: 24661312] [CrossRef]
36.
Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y, Dobson R. Mobile phone text messaging and app-based interventions for smoking cessation. Cochrane Database Syst Rev 2019;10:. 10.1002/14651858.CD006611.pub5 CD006611 [PMC free article: PMC6804292] [PubMed: 31638271] [CrossRef]
37.
Hebert ET, Ra CK, Alexander AC, Helt A, Moisiuc R, Kendzor DE, et al. A mobile just-in-time adaptive intervention for smoking cessation: pilot randomized controlled trial. J Med Internet Res 2020;22:e16907. 10.2196/16907 [PMC free article: PMC7091024] [PubMed: 32149716] [CrossRef]
38.
McClernon FJ, Roy CR. I am your smartphone and I know you are about to smoke: the application of mobile sensing and computing approaches to smoking research and treatment. Nicotine Tob Res 2013;15:1651–4. 10.1093/ntr/ntt054 [PMC free article: PMC3768335] [PubMed: 23703731] [CrossRef]
39.
Naughton F. Delivering ‘Just-In-Time’ smoking cessation support via mobile phones: current knowledge and future directions. Nicotine Tob Res 2016;19(3):379–83. 10.1093/ntr/ntw143 [PubMed: 27235703] [CrossRef]
40.
Naughton F, Brown C, High J, Notley C, Mascolo C, Coleman T, et al. Randomised controlled trial of a just-in-time adaptive intervention (JITAI) smoking cessation smartphone app: the Quit Sense feasibility trial protocol. BMJ Open 2021;11:e048204. 10.1136/bmjopen-2020-048204 [PMC free article: PMC8076923] [PubMed: 33903144] [CrossRef]
41.
Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, et al.; REDCap Consortium. The REDCap consortium: building an international community of software platform partners. J Biomed Inform 2019;95:103208. 10.1016/j.jbi.2019.103208 [PMC free article: PMC7254481] [PubMed: 31078660] [CrossRef]
42.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377–81. 10.1016/j.jbi.2008.08.010 [PMC free article: PMC2700030] [PubMed: 18929686] [CrossRef]
43.
Office for National Statistics. The National Statistics Socio-Economic Classification User Manual. Basingstoke: ONS; 2005.
44.
Naughton F, Prevost AT, Gilbert H, Sutton S. Randomised controlled trial evaluation of a tailored leaflet and SMS text message self-help intervention for pregnant smokers (MiQuit). Nicotine Tob Res 2012;14:569–77. 10.1093/ntr/ntr254 [PubMed: 22311960] [CrossRef]
45.
Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice-Hall; 1986.
46.
Michie S, Richardson M, Johnston M, Abraham C, Francis J, Hardeman W, et al. The behavior change technique taxonomy (v1) of 93 hierarchically clustered techniques: building an international consensus for the reporting of behavior change interventions. Ann Behav Med 2013;46:81–95. 10.1007/s12160-013-9486-6 [PubMed: 23512568] [CrossRef]
47.
Michie S, Hyder N, Walia A, West R. Development of a taxonomy of behaviour change techniques used in individual behavioural support for smoking cessation. Addict Behav 2011;36:315–9. 10.1016/j.addbeh.2010.11.016 [PubMed: 21215528] [CrossRef]
48.
West R, Hajek P. Evaluation of the mood and physical symptoms scale (MPSS) to assess cigarette withdrawal. Psychopharmacology (Berl) 2004;177:195–9. 10.1007/s00213-004-1923-6 [PubMed: 15179542] [CrossRef]
49.
Fidler JA, Shahab L, West R. Strength of urges to smoke as a measure of severity of cigarette dependence: comparison with the Fagerstrom Test for Nicotine Dependence and its components. Addiction 2011;106:631–8. 10.1111/j.1360-0443.2010.03226.x [PubMed: 21134020] [CrossRef]
50.
Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655. 10.1136/bmj.a1655 [PMC free article: PMC2769032] [PubMed: 18824488] [CrossRef]
51.
Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res 2011;20:1727–36. 10.1007/s11136-011-9903-x [PMC free article: PMC3220807] [PubMed: 21479777] [CrossRef]
52.
West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100:299–303. 10.1111/j.1360-0443.2004.00995.x [PubMed: 15733243] [CrossRef]
53.
Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ, et al. Biochemical verification of tobacco use and abstinence: 2019 update. Nicotine Tob Res 2019;22:1086–97. 10.1093/ntr/ntz132 [PMC free article: PMC7882145] [PubMed: 31570931] [CrossRef]
54.
Jacob P, 3rd, Hatsukami D, Severson H, Hall S, Yu L, Benowitz Neal L. Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. Cancer Epidemiol Biomarkers Prev 2002;11:1668–73. [PubMed: 12496059]
55.
Cheung KL, de Ruijter D, Hiligsmann M, Elfeddali I, Hoving C, Evers SMAA, de Vries H. Exploring consensus on how to measure smoking cessation. A Delphi study. BMC Public Health 2017;17:890. 10.1186/s12889-017-4902-7 [PMC free article: PMC5696733] [PubMed: 29162043] [CrossRef]
56.
Gwaltney CJ, Shiffman S, Balabanis MH, Paty JA. Dynamic self-efficacy and outcome expectancies: prediction of smoking lapse and relapse. J Abnorm Psychol 2005;114:661–75. 10.1037/0021-843X.114.4.661 [PubMed: 16351387] [CrossRef]
57.
Smith SS, Piper ME, Bolt DM, Fiore MC, Wetter DW, Cinciripini PM, Baker TB. Development of the brief Wisconsin Inventory of Smoking Dependence Motives. Nicotine Tob Res 2010;12:489–99. 10.1093/ntr/ntq032 [PMC free article: PMC2861888] [PubMed: 20231242] [CrossRef]
58.
Teare MD, Dimairo M, Shephard N, Hayman A, Whitehead A, Walters SJ. Sample size requirements to estimate key design parameters from external pilot randomised controlled trials: a simulation study. Trials 2014;15:264. 10.1186/1745-6215-15-264 [PMC free article: PMC4227298] [PubMed: 24993581] [CrossRef]
59.
Brown J, Michie S, Geraghty AW, Yardley L, Gardner B, Shahab L, et al. Internet-based intervention for smoking cessation (StopAdvisor) in people with low and high socioeconomic status: a randomised controlled trial. Lancet Respir Med 2014;2:997–1006. 10.1016/S2213-2600(14)70195-X [PubMed: 25262458] [CrossRef]
60.
Bricker JB, Mull KE, Kientz JA, Vilardaga R, Mercer LD, Akioka KJ, Heffner JL. Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy. Drug Alcohol Depend 2014;143:87–94. 10.1016/j.drugalcdep.2014.07.006 [PMC free article: PMC4201179] [PubMed: 25085225] [CrossRef]
61.
Taylor GMJ, Dalili MN, Semwal M, Civljak M, Sheikh A, Car J. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev 2017;9:. 10.1002/14651858.CD007078.pub5 CD007078 [PMC free article: PMC6703145] [PubMed: 28869775] [CrossRef]
62.
Whittaker R, McRobbie H, Bullen C, Rodgers A, Gu Y. Mobile phone-based interventions for smoking cessation. Cochrane Database Syst Rev 2016;4:. 10.1002/14651858.CD006611.pub4 CD006611 [PMC free article: PMC6485940] [PubMed: 27060875] [CrossRef]
63.
Iacoviello BM, Steinerman JR, Klein DB, Silver Theodore L, Berger AG, Luo SX, Schork NJ. Clickotine, a personalized smartphone app for smoking cessation: initial evaluation. JMIR Mhealth Uhealth 2017;5:e56. 10.2196/mhealth.7226 [PMC free article: PMC5424127] [PubMed: 28442453] [CrossRef]
64.
Mason D, Gilbert H, Sutton S. Effectiveness of web-based tailored smoking cessation advice reports (iQuit): a randomized trial. Addiction 2012;107:2183–90. 10.1111/j.1360-0443.2012.03972.x [PubMed: 22690882] [CrossRef]
65.
Burton PR, Gurrin LC, Campbell MJ. Clinical significance not statistical significance: a simple Bayesian alternative to p values. J Epidemiol Community Health 1998;52:318–23. 10.1136/jech.52.5.318 [PMC free article: PMC1756718] [PubMed: 9764283] [CrossRef]
66.
Fleiss JL. Statistical Methods for Rates and Proportions. 2nd edn. New York: John Wiley; 1981.
67.
Jones KC, Burns A. Unit Costs of Health and Social Care 2021. Kent, UK: Personal Social Services Research Unit; 2021. 10.22024/UniKent/01.02.92342 [CrossRef]
68.
National Institute for Health and Clinical Excellence (NICE). Position Statement on Use of the EQ-5D-5L Valuation Set (updated October 2019). 2019. URL: https://www​.nice.org​.uk/about/what-we-do​/our-programmes/nice-guidance​/technology-appraisal-guidance​/eq-5d-5l (accessed 1 March 2024).
69.
van Hout B, Janssen MF, Feng YS, Kohlmann T, Busschbach J, Golicki D, et al. Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health 2012;15:708–15. 10.1016/j.jval.2012.02.008 [PubMed: 22867780] [CrossRef]
70.
Willan AR, Briggs AH, Hoch JS. Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Econ 2004;13:461–75. 10.1002/hec.843 [PubMed: 15127426] [CrossRef]
71.
National Institute for Health and Clinical Excellence (NICE). Guide to the Methods of Technology Appraisal 2013. 2013. URL: https://www​.nice.org​.uk/process/pmg9/chapter/foreword (accessed 1 March 2024). [PubMed: 27905712]
72.
Moore GF, Audrey S, Barker M, Bond L, Bonell C, Hardeman W, et al. Process evaluation of complex interventions: Medical Research Council guidance. BMJ 2015;350:h1258. 10.1136/bmj.h1258 [PMC free article: PMC4366184] [PubMed: 25791983] [CrossRef]
73.
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006;3:77–101. 10.1191/1478088706qp063oa [CrossRef]
74.
Stinnett AA, Mullahy J. Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998;18:S68–80. 10.1177/0272989X98018002S09 [PubMed: 9566468] [CrossRef]
75.
Masaki K, Tateno H, Nomura A, Muto T, Suzuki S, Satake K, et al. A randomized controlled trial of a smoking cessation smartphone application with a carbon monoxide checker. NPJ Digit Med 2020;3:35. 10.1038/s41746-020-0243-5 [PMC free article: PMC7067789] [PubMed: 32195370] [CrossRef]
76.
McCarthy DE, Minami H, Yeh VM, Bold KW. An experimental investigation of reactivity to ecological momentary assessment frequency among adults trying to quit smoking. Addiction 2015;110:1549–60. 10.1111/add.12996 [PMC free article: PMC4565778] [PubMed: 26011583] [CrossRef]
77.
Berg ML, Cheung KL, Hiligsmann M, Evers S, de Kinderen RJA, Kulchaitanaroaj P, Pokhrel S. Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review. Addiction 2017;112:946–67. 10.1111/add.13748 [PMC free article: PMC5434798] [PubMed: 28060453] [CrossRef]
78.
Coleman T, Clark M, Welch C, Whitemore R, Leonardi-Bee J, Cooper S, et al. Effectiveness of offering tailored text message, self-help smoking cessation support to pregnant women who want information on stopping smoking: MiQuit3 randomised controlled trial and meta-analysis. Addiction 2022;117:1079–94. 10.1111/add.15715 [PubMed: 34636086] [CrossRef]
79.
Yardley L, Spring BJ, Riper H, Morrison LG, Crane DH, Curtis K, et al. Understanding and promoting effective engagement with digital behavior change interventions. Am J Prev Med 2016;51:833–42. 10.1016/j.amepre.2016.06.015 [PubMed: 27745683] [CrossRef]
80.
Munafo M. Open science and research reproducibility. ecancermedicalscience 2016;10:ed56. 10.3332/ecancer.2016.ed56 [PMC free article: PMC4898932] [PubMed: 27350794] [CrossRef]
81.
Watson NL, Mull KE, Heffner JL, McClure JB, Bricker JB. Participant recruitment and retention in remote eHealth intervention trials: methods and lessons learned from a large randomized controlled trial of two web-based smoking interventions. J Med Internet Res 2018;20:e10351. 10.2196/10351 [PMC free article: PMC6128955] [PubMed: 30143479] [CrossRef]
82.
BinDhim NF, McGeechan K, Trevena L. Who uses smoking cessation apps? A feasibility study across three countries via smartphones. JMIR Mhealth Uhealth 2014;2:e4. 10.2196/mhealth.2841 [PMC free article: PMC4114511] [PubMed: 25098439] [CrossRef]
83.
BinDhim NF, McGeechan K, Trevena L. Smartphone Smoking Cessation Application (SSC App) trial: a multicountry double-blind automated randomised controlled trial of a smoking cessation decision-aid ‘app’. BMJ Open 2018;8:e017105. 10.1136/bmjopen-2017-017105 [PMC free article: PMC5780681] [PubMed: 29358418] [CrossRef]
84.
Jackson SE, Beard E, Angus C, Field M, Brown J. Moderators of changes in smoking, drinking and quitting behaviour associated with the first COVID-19 lockdown in England. Addiction 2022;117:772–83. 10.1111/add.15656 [PMC free article: PMC8652848] [PubMed: 34431577] [CrossRef]
85.
Ubhi HK, Kotz D, Michie S, van Schayck OCP, West R. A comparison of the characteristics of iOS and Android users of a smoking cessation app. Transl Behav Med 2017;7:166–71. 10.1007/s13142-016-0455-z [PMC free article: PMC5526810] [PubMed: 28168609] [CrossRef]
86.
Szinay D, Jones A, Chadborn T, Brown J, Naughton F. Influences on the uptake of and engagement with health and well-being smartphone apps: systematic review. J Med Internet Res 2020;22:e17572. 10.2196/17572 [PMC free article: PMC7293059] [PubMed: 32348255] [CrossRef]
87.
Szinay D, Perski O, Jones A, Chadborn T, Brown J, Naughton F. Perceptions of factors influencing engagement with health and well-being apps in the United Kingdom: qualitative interview study. JMIR Mhealth Uhealth 2021;9:e29098. 10.2196/29098 [PMC free article: PMC8726027] [PubMed: 34927597] [CrossRef]
88.
Office for National Statistics. Population Estimates by Ethnic Group and Religion, England and Wales: 2019. 2019. URL: www​.ons.gov.uk/peoplepopulationandcommunity​/populationandmigration​/populationestimates​/articles/populationestimatesbyethnicgroupandreligionenglandandwales/2019 (accessed 20 March 2022).
Copyright © 2024 Naughton et al.

This work was produced by Naughton et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

Bookshelf ID: NBK603177
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (3.6M)

Other titles in this collection

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...